Endothelial Outgrowth Cells Are Not Derived From CD133 + Cells or CD45 + Hematopoietic Precursors
Male
0301 basic medicine
Adolescent
Infant, Newborn
Endothelial Cells
Bone Marrow Cells
Cell Differentiation
Cell Separation
Fetal Blood
Flow Cytometry
Hematopoietic Stem Cells
03 medical and health sciences
Antigens, CD
Humans
Leukocyte Common Antigens
Female
AC133 Antigen
Child
Peptides
Biomarkers
Cells, Cultured
Glycoproteins
DOI:
10.1161/atvbaha.107.144972
Publication Date:
2007-05-11T01:40:33Z
AUTHORS (9)
ABSTRACT
Objective— Two types of endothelial progenitor cells (EPCs), early EPCs and late (also called outgrowth [EOCs]), were described in vitro previously. In this report, we dissect the phenotype precursor(s) that generate these cell with focus on markers CD34, CD133, vascular growth factor receptor-2 (VEGFR2) have been used to identify putative circulating precursors. We also included CD45 analysis assess relation between CD34 + hematopoietic progenitors (HPC), precursors, both generated EPC types. Addressing issue might lead a better understanding lineage give rise may contribute consensus their flowcytometric enumeration. Methods Results— Using sorting human cord blood (UCB) bone marrow (BM) cells, demonstrate EOC generating precursors are confined small − fraction, but not HPC nor any other subpopulation. monocytic displayed characteristics typical for EPCs. Phenotypic showed express VEGFR2 whereas CD133 as expected, VEGFR2. Conclusion— EOCs derived from or
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (24)
CITATIONS (279)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....